This website uses cookies

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.

Product Finder

Protein

Sequence

Shop

peptides&elephants sells products and services to companies and non-profit institutions only and not to individuals without business or academic affiliations.

Name Price  
Adenovirus PEP-LIPS Peptide Pool 25 EUR Add to cart

Description

No. of peptides
5
Amount
approx. 25µg / peptide
Purity (HPLC)
≥ 95%
Remark
The peptides of this product are supplied as trifluoracetate salts. This pool consists of 5 peptides, each corresponding to a defined HLA class I-restricted T cell epitope from adenovirus.
Storage
Store at -20°C
Solubility
Dissolve in a minimum amount of pure DMSO (approx. 40µl) and dilute with PBS buffer to the desired concentration. Please pay attention that the final concentration of DMSO must be below 1% (v/v) to avoid toxicity in the biological system.

 
Sequences

No.

Sequence

C-Terminus

Length

Source

1

TDLGQNLLY

-COOH

9

ADV hexon 886-894

HLA-A*01:01

2

GQQSMPNRPNYIAFR

-COOH

15

ADV hexon 316-330

HLA-A*03:01
HLA-B*35:01

3

TYFSLNNKF

-COOH

9

ADV hexon 37-45

HLA-A*24:02

4

KPYSGTAYNAL

-COOH

11

ADV hexon 114-124

HLA-A*07:02

5

MPNRPNYIAFRDNFI

-COOH

15

ADV hexon 320-334

HLA-A*35:01

BCR-ABL PEP-LIPS Peptide Pool 25 EUR Add to cart

Description

No. of peptides
6
Amount
approx. 25µg / peptide
Purity (HPLC)
≥ 95%
Remark
The peptides of this product are supplied as trifluoracetate salts. This pool consists of 6 peptides, each corresponding to a defined HLA class I-restricted T cell epitope from BCR-ABL fusion protein.
Storage
Store at -20°C
Solubility
Dissolve in a minimum amount of pure DMSO (approx. 40µl) and dilute with PBS buffer to the desired concentration. Please pay attention that the final concentration of DMSO must be below 1% (v/v) to avoid toxicity in the biological system.

 
Sequences

No.

Sequence

C-Terminus

Length

Source

1

GVRGRVEEI

-COOH

9

BCR-ABL

HLA-A*02:01

2

SSKALQRPV

-COOH

9

BCR-ABL 926-934

HLA-A*02:01

3

KQSSKALQR

-COOH

9

BCR-ABL 924-932

HLA-A*03:01

4

KQSSKALQRPV

-COOH

11

BCR-ABL 924-934

HLA-A*03:01

5

ATGFKQSSK

-COOH

9

BCR-ABL 259-269

HLA-A*03:01

HLA-A*11:01

6

GFKQSSKAL

-COOH

9

BCR-ABL 922-930

HLA-A*08:01

CEF (advanced)- PEP-LIPS Peptide Pool 45 EUR Add to cart

Description

No. of peptides
32 peptides
Amount
approx. 25μg / peptide
Purity (HPLC)
≥ 95%
Remark
The peptides of this product are supplied as trifluoracetate salts. This pool consists of 32 peptides, each corresponding to a defined HLA class I-restricted T-cell epitope from Cytomegalovirus, Epstein- Barr virus and Influenza virus
Storage
Store at -20°C
Solubility
Dissolve in a minimum amount of pure DMSO (approx. 40μl) and dilute with PBS buffer to the desired concentration. Please pay attention that the final concentration of DMSO must be below 1% (v/v) to avoid toxicity in the biological system.

No.

Sequence

C-Termini

Length

Source

1

VSDGGPNLY

-COOH

9

A1 Influenza A

HLA-A1

2

CTELKLSDY

-COOH

9

Influenza A

HLA-A1

3

GILGFVFTL

-COOH

9

A2 Influenza M

HLA-A2

4

FMYSDFHFI

-COOH

9

A2 Influenza A

HLA-A2

5

CLGGLLTMV

-COOH

9

EBV LMP2A

HLA-A2

6

GLCTLVAML

-COOH

9

EBV BMLF1

HLA-A2

7

NLVPMVATV

-COOH

9

A0201 HCMV pp65

HLA-A2

8

KTGGPIYKR

-COOH

9

AA68 Influenza NP

HLA-A3

9

RVLSFIKGTK

-COOH

10

Influenza NP

HLA-A3

10

ILRGSVAHK

-COOH

9

Influenza A

HLA-A3

11

RVRAYTYSK

-COOH

9

EBV

HLA-A3

12

RLRAEAQVK

-COOH

9

EBV

HLA-A3

13

SIIPSGPLK

-COOH

9

Influenza M

HLA-A3/A11/A6

14

AVFDRKSDAK

-COOH

10

EBV EBNA 4NP

HLA-A11

15

IVTDFSVIK

-COOH

9

EBV

HLA-A11

16

ATIGTAMYK

-COOH

9

EBV

HLA-A11

17

DYCNVLNKEF

-COOH

10

A24 EBV RTA

HLA-A24

18

LPFDKTTVM

-COOH

9

Influenza NP

HLA-B7

19

RPPIFIRRL

-COOH

9

EBV

HLA-B7

20

ELRSRYWAI

-COOH

9

B8 Influenza NP

HLA-B8

21

RAKFKQLL

-COOH

8

EBV BZLF-1

HLA-B8

22

FLRGRAYGL

-COOH

9

EBV EBNA 3A

HLA-B8

23

QAKWRLQTL

-COOH

9

EBV EBNA 3

HLA-B8

24

SDEEEAIVAYTL

-COOH

12

HCMV

HLA-B18

25

SRYWAIRTR

-COOH

9

B27 Influenza NP

HLA-B27

26

ASCMGLIY

-COOH

8

Influenza A

HLA-B27

27

RRIYDLIEL

-COOH

9

EBV EBNA 3C

HLA-B27

28

YPLHEQHGM

-COOH

9

B35 EBV EBNA3A

HLA-B35

29

IPSINVHHY

-COOH

9

CMV pp65

HLA-B35

30

EENLLDFVRF

-COOH

10

B44 EBV

HLA-B44

31

EFFWDANDIY

-COOH

10

HCMV

HLA-B44

32

TPRVTGGGAM

-COOH

10

B0702 HCMV

HLA-B7

CEF (classic)- PEP-LIPS Peptide Pool 35 EUR Add to cart

Description

No. of peptides
23 peptides
Amount
approx. 25μg / peptide
Purity (HPLC)
≥ 95%
Remark
The peptides of this product are supplied as trifluoracetate salts. This pool consists of 23 peptides, each corresponding to a defined HLA class I-restricted T-cell epitope from Cytomegalovirus, Epstein-Barr virus and Influenza virus
Storage
Store at -20°C
Solubility
Dissolve in a minimum amount of pure DMSO (approx. 40μl) and dilute with PBS buffer to the desired concentration. Please pay attention that the final concentration of DMSO must be below 1% (v/v) to avoid toxicity in the biological system.

 
Sequences

No.

Sequence

C-Terminus

Length

Source

1

VSDGGPNLY

-COOH

9

Influenza A

HLA-A1

2

CTELKLSDY

-COOH

9

Influenza A

HLA-A1

3

GILGFVFTL

-COOH

9

Influenza M

HLA-A2

4

GLCTLVAML

-COOH

9

EBV BMLF1

HLA-A2

5

NLVPMVATV

-COOH

9

HCMV pp65

HLA-A2

6

KTGGPIYKR

-COOH

9

Influenza NP

HLA-A68

7

ILRGSVAHK

-COOH

9

Influenza A

HLA-A3

8

RVRAYTYSK

-COOH

9

EBV

HLA-A3

9

RLRAEAQVK

-COOH

9

EBV

HLA-A3

10

IVTDFSVIK

-COOH

9

EBV

HLA-A11

11

ATIGTAMYK

-COOH

9

EBV

HLA-A11

12

DYCNVLNKEF

-COOH

10

EBV RTA

HLA-A24

13

RPPIFIRRL

-COOH

9

EBV

HLA-B7

14

ELRSRYWAI

-COOH

9

B8 Influenza NP

HLA-B8

15

RAKFKQLL

-COOH

8

EBV BZLF-1

HLA-B7

16

FLRGRAYGL

-COOH

9

EBV EBNA 3A

HLA-B7

17

QAKWRLQTL

-COOH

9

EBV EBNA 3

HLA-B7

18

SRYWAIRTR

-COOH

9

B27 Influenza NP

HLA-B27

19

RRIYDLIEL

-COOH

9

EBV EBNA 3C

HLA-B27

20

YPLHEQHGM

-COOH

9

B35 EBV EBNA3A

HLA-B35

21

EENLLDFVRF

-COOH

10

B44 EBV

HLA-B44

22

EFFWDANDIY

-COOH

10

HCMV

HLA-B44

23

TPRVTGGGAM

-COOH

10

B0702 HCMV

HLA-B7

CMV PEP-LIPS Peptide Pool 25 EUR Add to cart

Description

No. of peptides
14
Amount
approx. 25µg / peptide
Purity (HPLC)
≥ 95%
Remark
The peptides of this product are supplied as trifluoracetate salts. This pool consists of 14 peptides, each corresponding to a defined HLA class I-restricted T cell epitope from cytomegalovirus (CMV).
Storage
Store at -20°C
Solubility
Dissolve in a minimum amount of pure DMSO (approx. 40µl) and dilute with PBS buffer to the desired concentration. Please pay attention that the final concentration of DMSO must be below 1% (v/v) to avoid toxicity in the biological system.

 
Sequences

No.

Sequence

C-Terminus

Length

Source

1

VTEHDTLLY

-COOH

9

CMV pp50 245-253

HLA-A*01:01

2

YSEHPTFTSQY

-COOH

11

CMV pp65 363-373

HLA-A*01:01

3

NLVPMVATV

-COOH

9

CMV pp65 495-503

HLA-A*02:01

4

VLAELVKQI

-COOH

9

CMV IE1 81-89

HLA-A*02:01

5

VLEETSVML

-COOH

9

CMV IE-1 316-324

HLA-A*02:01

6

KLGGALQAK

-COOH

9

CMV IE1 184-192

HLA-A*03:01

7

QYDPVAALF

-COOH

9

CMV pp65 341-349

HLA-A*24:02

8

VYALPLKML

-COOH

9

CMV pp65 113-121

HLA-A*24:02

9

RPHERNGFTVL

-COOH

11

CMV pp65 265-275

HLA-B*07:02

10

TPRVTGGGAM

-COOH

10

CMV pp65 417-426

HLA-B*07:02

11

QIKVRVDMV

-COOH

9

CMV IE-1 88-96

HLA-B*08:01

12

SDEEEAIVAYTL

-COOH

12

CMV IE-1 378-389

HLA-B*18

13

EFFWDANDIY

-COOH

10

CMV pp65 512-521

HLA-B*44:02

14

IPSINVHHY

-COOH

9

CMV pp65 123-131

HLA-B*35:01

EBV PEP-LIPS Peptide Pool 45 EUR Add to cart

Description

No. of peptides
26
Amount
approx. 25µg / peptide
Purity (HPLC)
≥ 95%
Remark
This pool consists of 26 peptides, each corresponding to a defined HLA class I-restricted T cell epitope from Epstein-Barr virus (EBV).
Storage
Store at -20°C
Solubility
Dissolve in a minimum amount of pure DMSO (approx. 40µl) and dilute with PBS buffer to the desired concentration. Please pay attention that the final concentration of DMSO must be below 1% (v/v) to avoid toxicity in the biological system.

 
Sequences

No.

Sequence

C-Terminus

Length

Source

1

CLGGLLTMV

-COOH

9

EBV LMP-2 426-434

HLA-A*02:01

2

GLCTLVAML

-COOH

9

EBV BMLF-1 280-288

HLA-A*02:01

3

FLDKGTYTL

-COOH

9

EBV BALF-4 276–284

HLA-A*02:01

4

FLYALALLL

-COOH

9

EBV LMP-2 356-364

HLA-A*02:01

5

YLLEMLWRL

-COOH

9

EBV LMP-1 125-133

HLA-A*02:01

6

RVRAYTYSK

-COOH

9

EBV BRLF-1 148-156

HLA-A*03:01

7

RLRAEAQVK

-COOH

9

EBV EBNA-3A 603-611

HLA-A*03:01

8

ATIGTAMYK

-COOH

9

EBV BRLF1 134-142

HLA-A*11:01

9

AVFDRKSDAK

-COOH

10

EBV EBNA 3B 399-408

HLA-A*11:01

10

IVTDFSVIK

-COOH

9

EBV EBNA3B 416-424

HLA-A*11:01 HLA-A*68:01

11

SSCSSCPLSK

-COOH

10

EBV LMP-2 340-349

HLA-A*11:01

12

DYCNVLNKEF

-COOH

10

EBV BRLF1 28-37

HLA-A*24:02

13

PYLFWLAAI

-COOH

9

EBV LMP2 131-139

HLA-A*24:02

14

TYGPVFMCL

-COOH

9

EBV LMP-2 419-427

HLA-B*24:02

15

TYGPVFMSL

-COOH

9

EBV LMP2 419–427

HLA-A*24:02

16

RPPIFIRRL

-COOH

9

EBV EBNA-3A 247-255

HLA-B*07:02

17

QPRAPIRPI

-COOH

9

EBV EBNA-3C 881-889

HLA-B*07:02

18

FLRGRAYGL

-COOH

9

EBV EBNA-3A 325-333

HLA-B*08:01

19

RAKFKQLL

-COOH

8

EBV BZLF-1 190-197

HLA-B*08:01

20

RRIYDLIEL

-COOH

9

EBV EBNA 3C 258-266

HLA-B*27:02
HLA-B*27:05
HLA-B*27:04

21

YPLHEQHGM

-COOH

9

EBV EBNA-3A 458-466

HLA-B*35:01

22

EPLPQGQLTAY

-COOH

11

EBV BZLF-1 54-64

HLA-B*35:01

23

HPVGEADYFEY

-COOH

11

EBV EBNA-1 407-417

HLA-B*35:01

24

IEDPPFNSL

-COOH

9

EBV LMP2 200-208

HLA-B*40:01

25

EENLLDFVRF

-COOH

10

EBV EBNA3C 281–290

HLA-B*44:05

26

QAKWRLQTL

-COOH

9

EBV EBNA3A 158-166

HLA-B*08:01

gp100 (pmel17) PEP-LIPS Peptide Pool 25 EUR Add to cart

Description

No. of peptides
8
Amount
approx. 25µg / peptide
Purity (HPLC)
≥ 95%
Remark
The peptides of this product are supplied as trifluoracetate salts. This pool consists of 8 peptides, each corresponding to a defined HLA class I-restricted T cell epitope from gp100 (pmel17).
Storage
Store at -20°C
Solubility
Dissolve in a minimum amount of pure DMSO (approx. 40µl) and dilute with PBS buffer to the desired concentration. Please pay attention that the final concentration of DMSO must be below 1% (v/v) to avoid toxicity in the biological system.

 
Sequences

No.

Sequence

C-Terminus

Length

Source

1

IMDQVPFSV

-COOH

9

gp100 209-217 Met2

HLA-A*02:01

2

ITDQVPFSV

-COOH

9

gp100 209-217

HLA-A*02:01

3

KTWGQYWQV

-COOH

9

gp100 154-162

HLA-A*02:01

4

VLYRYGSFSV

-COOH

10

gp100 476-485

HLA-A*02:01

5

YLEPGPVTA

-COOH

9

gp100 280-288

HLA-A*02:01

6

YLEPGPVTV

-COOH

9

gp100 280-288 Val288

HLA-A*02:01

7

ALLAVGATK

-COOH

9

gp100 17-25

HLA-A*03:01

HLA-A*33:01  

8

VYFFLPDHL

-COOH

9

gp100 170-178

HLA-A*24:02

HBV PEP-LIPS Peptide Pool 25 EUR Add to cart

Description

No. of peptides
9
Amount
approx. 25µg / peptide
Purity (HPLC)
≥ 95%
Remark
This pool consists of 9 peptides, each corresponding to a defined HLA class I-restricted T cell epitope from Hepatitis B virus (HBV).
Storage
Store at -20°C
Solubility
Dissolve in a minimum amount of pure DMSO (approx. 40µl) and dilute with PBS buffer to the desired concentration. Please pay attention that the final concentration of DMSO must be below 1% (v/v) to avoid toxicity in the biological system.

 
Sequences

No.

Sequence

C-Terminus

Length

Source

1

FLLSLGIHL

-COOH

9

HBV polymerase 575-583

HLA-A*02:01

2

FLLTRILTI

-COOH

9

HBV envelope 183-191

HLA-A*02:01

3

FLPSDFFPSI

-COOH

10

HBV core 18-27 (subtype ADR4)

HLA-A*02:01

4

FLPSDFFPSV

-COOH

10

HBV core 18-27

HLA-A*02:01

5

GLSPTVWLSV

-COOH

10

HBV envelope 348-357

HLA-A*02:01

6

WLSLLVPFV

-COOH

9

HBV envelope 335-343

HLA-A*02:01

7

YVNVNMGLK

-COOH

9

HBV core antigen 88-96

HLA-A*11:01

8

EYLVSFGVW

-COOH

9

HBV core 117-125

HLA-A*24:02

9

KYTSFPWLL

-COOH

9

HBV polymerase 756-764

HLA-A*24:02

HCV PEP-LIPS Peptide Pool 35 EUR Add to cart

Description

No. of peptides
21
Amount
approx. 25µg / peptide
Purity (HPLC)
≥ 95%
Remark
This pool consists of 21 peptides, each corresponding to a defined HLA class I-restricted T cell epitope from Hepatitis C virus (HCV).
Storage
Store at -20°C
Solubility
Dissolve in a minimum amount of pure DMSO (approx. 40µl) and dilute with PBS buffer to the desired concentration. Please pay attention that the final concentration of DMSO must be below 1% (v/v) to avoid toxicity in the biological system.

 
Sequences

No.

Sequence

C-Terminus

Length

Source

1

ATDALMTGF

-COOH

9

HCV NS3 1436-1444

HLA-A*01:01

2

ATDALMTGY

-COOH

9

HCV NS3 1436-1444 (Y9)

HLA-A*01:01

3

ALYDVVTKL

-COOH

9

HCV NS5B 2594-2602

HLA-A*02:01

4

CINGVCWTV

-COOH

10

HCV NS3 1073-1081

HLA-A*02:01

5

CVNGVCWTV

-COOH

10

HCV NS3 1073-1081(V2)

HLA-A*02:01

6

DLMGYIPAV

-COOH

9

HCV core 132-140

HLA-A*02:01

7

DLMGYIPLV

-COOH

9

HCV core 132-140 (L8)

HLA-A*02:01

8

GLQDCTMLV

-COOH

9

HCV NS5B 2727-2735

HLA-A*02:01

9

KLSGLGINAV

-COOH

10

HCV NS3 1406-1415

HLA-A*02:01

10

KLVALGINAV

-COOH

10

HCV NS3 1406-1415 (V3)

HLA-A*02:01

11

LLFNILGGWV

-COOH

10

HCV NS4b 1807-1816

HLA-A*02:01

12

VLSDFKTWL

-COOH

9

HCV NS5a 1992-2200

HLA-A*02:01

13

YLLPRRGPRL

-COOH

10

HCV core 35-44

HLA-A*02:01

14

RVCEKMALY

-COOH

9

HCV NS5B 2588-2596

HLA-A*03:01

15

AYSQQTRGL

-COOH

9

HCV NS3 1031-1039

HLA-A*24:02

16

DPRRRSRNL

-COOH

9

HCV core 111-119

HLA-B*07:02

17

GPRLGVRAT

-COOH

9

HCV core 41-49

HLA-B*07:02

18

HSKKKCDEL

-COOH

9

HCV NS3 1395-1403

HLA-B*08:01

19

CPNSSIVY

-COOH

8

HCV E1 207-214

HLA-B*35:01

20

HPNIEEVAL

-COOH

9

HCV NS3 1359-1367

HLA-B*35:01

21

REISVPAEIL

-COOH

10

HCV NS5a 2266-2275

HLA-B*40:01

HIV PEP-LIPS Peptide Pool 35 EUR Add to cart

Description

No. of peptides
22
Amount
25µg / peptide
Purity (HPLC)
≥ 95%
Remark
The peptides of this product are supplied as trifluoracetate salts. This pool consists of 22 peptides, each corresponding to a defined HLA class I-restricted T cell epitope from human immunodeficiency virus (HIV).
Storage
Store at -20°C
Solubility
Dissolve in a minimum amount of pure DMSO (approx. 40µl) and dilute with PBS buffer to the desired concentration. Please pay attention that the final concentration of DMSO must be below 1% (v/v) to avoid toxicity in the biological system.

 
Sequences

No.

Sequence

C-Terminus

Length

Source

1

GLADQLIHL

-COOH

9

HIV-1 Vif 101-109

HLA-A*02:01

2

ILKEPVHGV

-COOH

9

HIV-1 RT 476-484

HLA-A*02:01

3

KLTPLCVTL

-COOH

9

HIV-1 env gp120 90-98

HLA-A*02:01

4

LTFGWCFKL

-COOH

9

HIV-1 Nef 137-145

HLA-A*02:01

5

SLYNTVATL

-COOH

9

HIV-1 p17 Gag 77-85

HLA-A*02:01

6

TLNAWVKVV

-COOH

9

HIV-1 gag p24 19-27

HLA-A*02:01

7

QVPLRPMTYK

-COOH

10

HIV-1 nef 73-82

HLA-A*03:01

8

RLRPGGKKK

-COOH

9

HIV-1 gag p17 20-28

HLA-A*03:01

9

RYLKDQQLL

-COOH

9

HIV Env gp160 585-593

HLA-A*24:02

10

RYPLTFGWCY

-COOH

10

HIV-1 Nef 134-143

HLA-A*24:02

11

GPGHKARVL

-COOH

9

HIV gag p24 223–231

HLA-B*07:02

12

IPRRIRQGL

-COOH

9

HIV-1 env gp120 843–851

HLA-B*07:02

13

TPGPGVRYPL

-COOH

10

HIV-1 nef 128-137

HLA-B*07:02

14

FLKEKGGL

-COOH

8

HIV-1 nef 90-97

HLA-B*08:01

15

GEIYKRWII

-COOH

9

HIV-1 gag p24 261-269

HLA-B*08:01

16

RLRPGGKKKY

-COOH

10

HIV-1 p17 20-29

HLA-B*15:01

17

GRAFVTIGK

-COOH

9

HIV Env 314-322

HLA-B*27:05

18

KRWIILGLNK

-COOH

10

HIV p24-Gag 263-272

HLA-B*27:05

19

KRWIIMGLNK

-COOH

10

HIV-1 Gag p24 263-272

HLA-B*27:05

20

NPDIVIYQY

-COOH

9

HIV-1 RT 330-338

HLA-B*35:01

21

VPLDEDFRKY

-COOH

10

HIV-1 RT 273-282

HLA-B*35:01

22

KEKGGLEGL

-COOH

9

HIV-1 Nef 92-100

HLA-B*40:01

HPV PEP-LIPS Peptide Pool 25 EUR Add to cart

Description

No. of peptides
14
Amount
25µg / peptide
Purity (HPLC)
≥ 95%
Remark
The peptides of this product are supplied as trifluoracetate salts. This pool consists of 14 peptides, each corresponding to a defined HLA class I-restricted T cell epitope from human papilloma virus (HPV).
Storage
Store at -20°C
Solubility
Dissolve in a minimum amount of pure DMSO (approx. 40µl) and dilute with PBS buffer to the desired concentration. Please pay attention that the final concentration of DMSO must be below 1% (v/v) to avoid toxicity in the biological system.

 
Sequences

No.

Sequence

C-Terminus

Length

Source

1

DLLLGTLNI

-COOH

9

HPV E7 81-89

HLA-A*02:01

2

TIHDIILECV

-COOH

10

HPV E6 29-38

HLA-A*02:01

3

YMLDLQPETT

-COOH

10

HPV 16 E7 11-20

HLA-A*02:01

4

ALQAIELQL

-COOH

9

HPV 16 E2 69–77

HLA-A*02:01

5

ICWGNQLFV

-COOH

9

HPV16 L1 349-357

HLA-A*02:01

6

KLCLRFLSK

-COOH

9

HPV 33 E6 64-72

HLA-A*03:01

7

CYSLYGTTL

-COOH

9

HPV E6 87-95

HLA-A*24:01

8

EYRHYCYSL

-COOH

9

HPV E6 75-83

HLA-A*24:02

9

HNIRGRWTGR

-COOH

10

HPV E6 133-142

HLA-A*68:01

10

AVPDDLYIK

-COOH

9

HPV L1 296-304

HLA-A11

11

GIVCPICSQK

-COOH

10

HPV E7 88-97

HLA-A11

12

KPTLKEYVL

-COOH

9

HPV 33 E7 5-13

HLA-B*07:02

13

FAFRDLCIVY

-COOH

10

HPV E6 52-61

HLA-B*35:01

14

HDIILECV

-COOH

8

HPV E6 31-38

HLA-B*40:02

hTERT PEP-LIPS Peptide Pool 25 EUR Add to cart

Description

No. of peptides
12
Amount
approx. 25µg / peptide
Purity (HPLC)
≥ 95%
Remark
The peptides of this product are supplied as trifluoracetate salts. This pool consists of 12 peptides, each corresponding to a defined HLA class I-restricted T cell epitope from Telomerase reverse transcriptase (hTERT).
Storage
Store at -20°C
Solubility
Dissolve in a minimum amount of pure DMSO (approx. 40µl) and dilute with PBS buffer to the desired concentration. Please pay attention that the final concentration of DMSO must be below 1% (v/v) to avoid toxicity in the biological system.

 
Sequences

No.

Sequence

C-Terminus

Length

Source

1

YAETKHFLY

-COOH

9

hTERT 325-333

HLA-A*01:01

2

ALLTSRLRFI

-COOH

10

hTERT 615-624

HLA-A*02:01

3

GLLGASVLGL

-COOH

10

hTERT 674-683

HLA-A*02:01

4

ILAKFLHWL

-COOH

9

hTERT 540-548

HLA-A*02:01

5

RLTSRVKAL

-COOH

9

hTERT 653-661

HLA-A*02:01

6

RLVDDFLLV

-COOH

9

hTERT 865-873

HLA-A*02:01

7

YLQVNSLQTV

-COOH

10

hTERT 988-997

HLA-A*02:01

8

KLFGVLRLK

-COOH

9

hTERT 973-981

HLA-A*03:01

9

VYAETKHFL

-COOH

9

hTERT 324-332

HLA-A*24:02

10

VYGFVRACL

-COOH

9

hTERT 461-469

HLA-A*24:02

11

APRCRAVRSL

-COOH

10

hTERT 4-13

HLA-A*07:02

12

APSFRQVSCL

-COOH

10

hTERT 68-77

HLA-A*07:02

Influenza PEP-LIPS Peptide Pool 35 EUR Add to cart

Description

No. of peptides
17
Amount
approx. 25µg / peptide
Purity (HPLC)
≥ 95%
Remark
This pool consists of 17 peptides, each corresponding to a defined HLA class I-restricted T cell epitope from influenza.
Storage
Store at -20°C
Solubility
Dissolve in a minimum amount of pure DMSO (approx. 40µl) and dilute with PBS buffer to the desired concentration. Please pay attention that the final concentration of DMSO must be below 1% (v/v) to avoid toxicity in the biological system.

 
Sequences

No.

Sequence

C-Terminus

Length

Source

1

ILGFVFTLTV

-COOH

10

Influenza A MP 59-68

HLA-A*02:01

2

ILRGSVAHK

-COOH

9

Influenza A (PR8) NP 265-274

HLA-A*03:01

3

KSMREEYRK

-COOH

9

Influenza A MP2 70-78

HLA-A*11:01

4

RMVLASTTAK

-COOH

10

Influenza A MP1 178-187

HLA-A*11:01

5

QPEWFRNVL

-COOH

9

Influenza A PB1 329-337

HLA-A*07:02

6

SPIVPSFDM

-COOH

9

Influenza A NP 473-481

HLA-A*07:02

7

CTELKLSDY

-COOH

9

Influenza A NP 44-52

HLA-A*01:01

8

VSDGGPNLY

-COOH

9

Influenza A PB1 591-599

HLA-A*01:01

9

FMYSDFHFI

-COOH

9

Influenza Virus PA 46-54

HLA-A*02:01

10

GILGFVFTL

-COOH

9

Influenza MP 58-66

HLA-A*02:01

11

RVLSFIKGTK

-COOH

10

Influenza Virus NP 342–351

HLA-A*03:01
HLA-A*31:01
HLA-A*33:01

12

SIIPSGPLK

-COOH

9

Influenza A MP 13-21

HLA-A*11:01

HLA-A*03:01
HLA-A*31:01
HLA-A*68:01

13

KTGGPIYKR

-COOH

9

Influenza Virus NP 91–99

HLA-A*68:01

14

ASCMGLIY

-COOH

8

Influenza Virus M1 128–135

HLA-B27
HLA
B35

15

SRYWAIRTR

-COOH

9

Influenza A NP 383-391

HLA-A*27:05

16

LPFDKTTVM

-COOH

9

Influenza NP 418-426

HLA-B*07:02

17

ELRSRYWAI

-COOH

9

Influenza Virus NP 380–388

HLA-B8

NY-ESO-1 PEP-LIPS Peptide Pool 25 EUR Add to cart

Description

No. of peptides
5 peptides
Amount
approx. 25µg / peptide
Purity (HPLC)
≥ 95%
Remark
The peptides of this product are supplied as trifluoracetate salts. This pool consists of 5 peptides, each corresponding to a defined HLA class I-restricted T cell epitope from NY-ESO-1
Storage
Store at -20°C
Solubility
Dissolve in a minimum amount of pure DMSO (approx. 40µl) and dilute with PBS buffer to the desired concentration. Please pay attention that the final concentration of DMSO must be below 1% (v/v) to avoid toxicity in the biological system.

 
Sequences

No.

Sequence

C-Terminus

Length

Source

1

SLLMWITQC

-COOH

9

NY-ESO-1 157-165 (C9)

HLA-A*02:01

2

SLLMWITQV

-COOH

9

NY-ESO-1 157-165

HLA-A*02:01

3

LLMWITQCF

-COOH

9

NY-ESO-1 158-166

HLA-A*24:02

4

TVSGNILTIR

-COOH

10

NY-ESO-1 127-136

HLA-A*68:01

5

MPFATPMEA

-COOH

9

NY-ESO-1 94-102

HLA-B*35:01
HLA-B*51:01

PSA PEP-LIPS Peptide Pool 25 EUR Add to cart

Description

No. of peptides
9
Amount
approx. 25µg / peptide
Purity (HPLC)
≥ 95%
Remark
The peptides of this product are supplied as trifluoracetate salts. This pool consists of 9 peptides, each corresponding to a defined HLA class I-restricted T cell epitope from prostate specific antigen (PSA).
Storage
Store at -20°C
Solubility
Dissolve in a minimum amount of pure DMSO (approx. 40µl) and dilute with PBS buffer to the desired concentration. Please pay attention that the final concentration of DMSO must be below 1% (v/v) to avoid toxicity in the biological system.

 
Sequences

No.

Sequence

C-Terminus

Length

Source

1

VSHSFPHPLY

-COOH

10

PSA 68-77b

HLA-A*01:01

2

FLTPKKLQCV

-COOH

10

PSA 141-150

HLA-A*02:01

3

KLQCVDLHV

-COOH

9

PSA 146-154

HLA-A*02:01

4

VISNDVCAQV

-COOH

10

PSA 154-163

HLA-A*02:01

5

YISNDVCAQV

-COOH

10

PSA 154-163 (Y1)

HLA-A*02:01

6

QVHPQKVTK

-COOH

9

PSA 162-170

HLA-A*03:01

7

CYASGWGSI

-COOH

9

PSA 153-161

HLA-A*24:02

8

HYRKWIKDTI

-COOH

10

PSA 248-257

HLA-A*24:02

9

GAAPLILSR

-COOH

9

PSA 16-24

HLA-A*11:01

HLA-A*31:01

HLA-A*33:01

PSMA PEP-LIPS Peptide Pool 25 EUR Add to cart

Description

No. of peptides
7
Amount
approx. 25µg / peptide
Purity (HPLC)
≥ 95%
Remark
The peptides of this product are supplied as trifluoracetate salts. This pool consists of 7 peptides, each corresponding to a defined HLA class I-restricted T cell epitope from prostate-specific membrane antigen (PSMA).
Storage
Store at -20°C
Solubility
Dissolve in a minimum amount of pure DMSO (approx. 40µl) and dilute with PBS buffer to the desired concentration. Please pay attention that the final concentration of DMSO must be below 1% (v/v) to avoid toxicity in the biological system.

 
Sequences

No.

Sequence

C-Terminus

Length

Source

1

LLHETDSAV

-COOH

9

PSMA 4-12

HLA-A*01:01

2

LLQERGVAYI

-COOH

10

PSMA 441-450

HLA-A*02:01

3

VLAGGFFLL

-COOH

9

PSMA 27-35

HLA-A*02:01

4

LYSDPADYF

-COOH

9

PSMA 227-235

HLA-A*24:02

5

NYARTEDFF

-COOH

9

PSMA 178-186

HLA-A*24:02

6

TSYVSFDSL

-COOH

9

PSMA 624-632

HLA-A*24:02

7

KVFRGNKVK

-COOH

9

PSMA 207-215

HLA-A*31:01

HLA-A*33:01  

RSV PEP-LIPS Peptide Pool 45 EUR Add to cart

Description

No. of peptides
28
Purity (HPLC)
≥ 95%
Remark
The peptides of this product are supplied as trifluoroacetate salts. This pool consists of 28 peptides, each corresponding to a defined HLA class I-restricted T cell epitope from Respiratory Syncytial Virus (RSV).
Storage
Store at - 20°C
Solubility
Dissolve in a minimum amount of pure DMSO (approx. 40 μl) and dilute with PBS buffer to the final concentration. Please note that the final concentration of DMSO must be below 1 % (v/v) to avoid toxicity in a biological system.

 
Sequences

No.

Sequence

C-Terminus

Length

Source

1

RELPRFMNYT

-COOH

10

RSV (A2) fusion glycoprotein F0 precursor 109-118

HLA-A*01:01

2

YLEKESIYY

-COOH

9

RSV MP 229-237

HLA-A*01:01

3

AITTILAAV

-COOH

9

RSV Fusion protein 10-18

HLA-A*02:02

4

ALLSTNKAV

-COOH

9

RSV Fusion protein 170-178

HLA-A*02:01

5

ELDKYKNAV

-COOH

9

RSV Fusion protein 82-90

HLA-A*02:01

6

FLLGVGSAI

-COOH

9

RSV Fusion protein 140-148

HLA-A*02:01

7

FMNYTLNNT

-COOH

9

RSV Fusion protein 114-122

HLA-A*02:01

8

HLEGEVNKI

-COOH

9

RSV Fusion protein 159-167

HLA-A*02:01

9

KIMTSKTDV

-COOH

9

RSV Fusion protein 394-402

HLA-A*02:01

10

KINQSLAFI

-COOH

9

RSV Fusion protein 498-506

HLA-A*02:01

11

KLMSNNVQI

-COOH

9

RSV Fusion protein 272-280

HLA-A*02:01

12

KMLKEMGEV

-COOH

9

RSV NP 137-145

HLA-A*02:01

13

KVLDLKNYI

-COOH

9

RSV Fusion protein 191-199

HLA-A*02:01

14

LLSLIAVGL

-COOH

9

RSV Fusion protein 538-546

HLA-A*02:01

15

LLSTNKAVV

-COOH

9

RSV Fusion protein 171-179

HLA-A*02:01

16

LMSNNVQIV

-COOH

9

RSV Fusion protein 273-281

HLA-A*02:01

17

QLLSSSKYT

-COOH

9

RSV NP 16-24

HLA-A*02:01

18

SLIAVGLLL

-COOH

9

RSV Fusion protein 540-548

HLA-A*02:01

19

SLSNGVSVL

-COOH

9

RSV Fusion protein 180-188

HLA-A*02:01

20

STNKAVVSL

-COOH

9

RSV Fusion protein 173-181

HLA-A*02:01

21

SVGNTLYYV

-COOH

9

RSV Fusion protein 451-459

HLA-A*02:01

22

YMLTNSELL

-COOH

9

RSV Fusion protein 250-258

HLA-A*02:01

23

RLPADVLKK

-COOH

9

RSV MP2 151-159

HLA-A*03:01

24

NPKASLLSL

-COOH

9

RSV NP 306-314

HLA-B*07:02

25

QVMLRWGVL

-COOH

9

RSV NP 255-263

HLA-B*08:01

26

AELDRTEEY

-COOH

9

RSV MP2 64-72

HLA-B44

27

RARRELPRF

-COOH

9

RSV Fusion glycoprotein F0 precursor 106-114

HLA-B57

28

IAVGLLLYC

-COOH

9

RSV Fusion glycoprotein F0 precursor 542-550

HLA-Cw12

Survivin PEP-LIPS Peptide Pool 25 EUR Add to cart

Description

No. of peptides
11
Amount
approx. 25µg / peptide
Purity (HPLC)
≥ 95%
Remark
The peptides of this product are supplied as trifluoracetate salts. This pool consists of 11 peptides, each corresponding to a defined HLA class I-restricted T-cell epitope from Survivin.
Storage
Store at -20°C
Solubility
Dissolve in a minimum amount of pure DMSO (approx. 40µl) and dilute with PBS buffer to the desired concentration. Please pay attention that the final concentration of DMSO must be below 1% (v/v) to avoid toxicity in the biological system.

 
Sequences

No.

Sequence

C-Terminus

Length

Source

1

MAEAGFIHY

-COOH

9

Survivin 38-46  (Y9)

HLA-A*01:01

2

PTENEPDLAY

-COOH

10

Survivin 47-56 (Y10)

HLA-A*01:01

3

ELTLGEFLKL

-COOH

10

Survivin 95-104

HLA-A*02:01

4

LMLGEFLKL

-COOH

9

Survivin 96-104

HLA-A*02:01

5

TLPPAWQPFL

-COOH

10

Survivin 5-14

HLA-A*02:01

6

RISTFKNWPK

-COOH

10

Survivin-3A 18-27 (K10)

HLA-A*03:01

7

DLAQCFFCFK

-COOH

10

Survivin 53-62

HLA-A*11:01

8

AYACNTSTL

-COOH

9

Survivin 80-88

HLA-A*24:02

9

STFKNWPFL

-COOH

9

Survivin 20-28

HLA-A*24:02

10

LPPAWQPFL

-COOH

9

Survivin 6-14

HLA-A*02:01

HLA-A*24:02

HLA-B*07:02 

11

EPDLAQCFY

-COOH

9

Survivin 51-59 (Y9)

 

HLA-B*35:01

Tyrosinase Peptide PEP-LIPS Peptide Pool 25 EUR Add to cart

Description

No. of peptides
6
Amount
approx. 25µg / peptide
Purity (HPLC)
≥ 95%
Remark
The peptides of this product are supplied as trifluoracetate salts. This pool consists of 6 peptides, each corresponding to a defined HLA class I-restricted T cell epitope from Tyrosinase.
Storage
Store at -20°C
Solubility
Dissolve in a minimum amount of pure DMSO (approx. 40µl) and dilute with PBS buffer to the desired concentration. Please pay attention that the final concentration of DMSO must be below 1% (v/v) to avoid toxicity in the biological system.

 
Sequences

No.

Sequence

C-Terminus

Length

Source

1

KSDICTDEY

-COOH

9

Tyrosinase 243-251 (S2)

HLA-A*01:01

2

SSDYVIPIGTY

-COOH

11

Tyrosinase 146-156

HLA-A*01:01

3

YMDGTMSQV

-COOH

9

Tyrosinase 369-377 (371D)

HLA-A*02:01

4

YMVPFIPLYR

-COOH

10

Tyrosinase 425-434

HLA-A*03:01

5

AFLPWHRLF

-COOH

9

Tyrosinase 206-214

HLA-A*24:02

6

LPWHRLFLL

-COOH

9

Tyrosinase 208-216

HLA-A*07:02

All prices are without taxes, customs charges, and shipping costs.

peptides&elephants sells products and services to companies and non-profit institutions only and not to individuals without business or academic affiliations.

Please inquire for bulk quantities of any of our catalogue peptides.

Products

We serve Peptides - for your perfect satisfaction with quality, price and support.
Our major PEP-LIPS products are high parallel customized peptide libraries and peptide pools.